speb/financial-data huggingface dataset:
CSTE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 200565000.00
CSTE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 123568000.00
CSTE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -41886000.00
CSTE balance_sheet (annual, 2024-12-31) — Total Tax Payable: 3585000.00
CSTE balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 3585000.00
CSTE income_statement (annual, 2024-12-31) — Total Unusual Items: -8911000.00
CSTE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -8911000.00
CSTE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 1103096.00
CSTE balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 1103096.00
CSTE balance_sheet (annual, 2024-12-31) — Treasury Stock: 39430000.00
CSTE balance_sheet (annual, 2024-12-31) — Work In Process: 1864000.00
CSTE balance_sheet (quarterly, 2024-12-31) — Work In Process: 1864000.00
CSTE balance_sheet (annual, 2024-12-31) — Working Capital: 196788000.00
CSTE income_statement (annual, 2024-12-31) — Write Off: 1007000.00
CSTE income_statement (quarterly, 2025-03-31) — +Operating Expense: 32497000.00
CSTE income_statement (quarterly, 2025-03-31) — +Total Revenue: 99558000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 51958000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 55848000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 166906000.00
CSTE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 34551999.00
CSTE income_statement (quarterly, 2025-03-31) — Basic EPS: -0.37
CSTE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 106336000.00
CSTE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1684000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 109897000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 371000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 88811000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 88811000.00
CSTE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -982000.00
CSTE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1658000.00
CSTE cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -15088000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -2272000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -743000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Inventory: -2220000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -3939000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 2630000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 110000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Payable: -2272000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -3015000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2906000.00
CSTE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -9340000.00
CSTE cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -8770000.00
CSTE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -17728000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Common Stock: 371000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 264818000.00
CSTE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 78388000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 55533000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Current Assets: 336004000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Current Debt: 3560000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 3560000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 151608000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 1524000.00
CSTE cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3424000.00
CSTE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 3424000.00
CSTE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 34551999.00
CSTE income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.37
CSTE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -12880000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 200000.00
CSTE income_statement (quarterly, 2025-03-31) — EBIT: -11327000.00
CSTE income_statement (quarterly, 2025-03-31) — EBITDA: -7903000.00
CSTE cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 203000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 2968000.00
CSTE cash_flow (quarterly, 2025-03-31) — End Cash Position: 88811000.00
CSTE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -982000.00
CSTE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -16772000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -14641000.00
CSTE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 10360000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 176000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 194144000.00
CSTE income_statement (quarterly, 2025-03-31) — Gross Profit: 21170000.00
CSTE income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 0.00
CSTE income_statement (quarterly, 2025-03-31) — Interest Income: 2463000.00
CSTE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 2463000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Inventory: 115255000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 268822000.00
CSTE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1658000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 3560000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 109897000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 444000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 110341000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 875000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Minority Interest: -3387000.00
CSTE income_statement (quarterly, 2025-03-31) — Minority Interests: 108000.00
CSTE income_statement (quarterly, 2025-03-31) — Net Income: -12880000.00
CSTE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -12880000.00
CSTE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -12988000.00
CSTE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -12880000.00
CSTE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -12880000.00
CSTE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -12988000.00
CSTE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -12988000.00
CSTE income_statement (quarterly, 2025-03-31) — Net Interest Income: 2463000.00
CSTE cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -982000.00
CSTE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 2463000.00
CSTE cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -28000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Net PPE: 194144000.00
CSTE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1630000.00
CSTE cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -982000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 264642000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 2704000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 2394000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 2704000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2394000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 2968000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 4818000.00
CSTE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -4477000.00
CSTE income_statement (quarterly, 2025-03-31) — Normalized Income: -10173460.00
CSTE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -15088000.00
CSTE cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -16000.00
CSTE income_statement (quarterly, 2025-03-31) — Operating Income: -11327000.00
CSTE income_statement (quarterly, 2025-03-31) — Operating Revenue: 99558000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 34549050.00
CSTE balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 40357000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -14641000.00
CSTE income_statement (quarterly, 2025-03-31) — Other Gand A: 10360000.00
CSTE income_statement (quarterly, 2025-03-31) — Other Income Expense: -3426000.00
CSTE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 3426000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 9753000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Other Properties: 194144000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Other Receivables: 76090000.00
CSTE income_statement (quarterly, 2025-03-31) — Other Special Charges: 3415000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Payables: 52158000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 107691000.00
CSTE cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: -9000.00
CSTE income_statement (quarterly, 2025-03-31) — Pretax Income: -12290000.00
CSTE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1684000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Receivables: 131938000.00
CSTE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 78388000.00
CSTE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3424000.00
CSTE income_statement (quarterly, 2025-03-31) — Research And Development: 1437000.00
CSTE income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 11000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 151612000.00
CSTE cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 54000.00
CSTE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 20700000.00
CSTE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 31060000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Share Issued: 34549050.00
CSTE income_statement (quarterly, 2025-03-31) — Special Income Charges: -3426000.00
CSTE cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 406000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 264818000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 264642000.00
CSTE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -719460.00
CSTE income_statement (quarterly, 2025-03-31) — Tax Provision: 698000.00
CSTE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CSTE balance_sheet (quarterly, 2025-03-31) — Total Assets: 539370000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 265262000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Total Debt: 113901000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 261431000.00
CSTE income_statement (quarterly, 2025-03-31) — Total Expenses: 110885000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 277939000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 203366000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 126331000.00
CSTE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -14753000.00
CSTE income_statement (quarterly, 2025-03-31) — Total Unusual Items: -3426000.00
CSTE income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -3426000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 39430000.00
CSTE balance_sheet (quarterly, 2025-03-31) — Working Capital: 184396000.00
CSTE income_statement (quarterly, 2025-06-30) — +Operating Expense: 30481000.00
CSTE income_statement (quarterly, 2025-06-30) — +Total Revenue: 101123000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 53512000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 54042000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 167188000.00
CSTE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 34559723.00
CSTE income_statement (quarterly, 2025-06-30) — Basic EPS: -0.54
CSTE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 88811000.00
CSTE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3637000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 114543000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 371000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 75626000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 75626000.00
CSTE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -311000.00
CSTE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3648000.00
CSTE cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -9879000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1285000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -3778000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Inventory: 2225000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 99000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 4746000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 287000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Payable: 1285000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -2493000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Receivables: -2312000.00
CSTE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2552000.00
CSTE cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 2992000.00
CSTE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -13838000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Common Stock: 371000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 252236000.00
CSTE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 81256000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 56573000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Current Assets: 323502000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Current Debt: 3231000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3231000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 148868000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Defined Pension Benefit: 1706000.00
CSTE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 3555000.00
CSTE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 3555000.00
CSTE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 34559723.00
CSTE income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.54
CSTE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -18554000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 235000.00
CSTE income_statement (quarterly, 2025-06-30) — EBIT: -10614000.00
CSTE income_statement (quarterly, 2025-06-30) — EBITDA: -7059000.00
CSTE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 653000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 3620000.00
CSTE cash_flow (quarterly, 2025-06-30) — End Cash Position: 75626000.00
CSTE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -311000.00
CSTE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -13516000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -8746000.00
CSTE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 9479000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 87000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 195650000.00
CSTE income_statement (quarterly, 2025-06-30) — Gross Profit: 19867000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Inventory: 115558000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 255908000.00
CSTE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3648000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 3231000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 114543000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 441000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 114984000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 853000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Minority Interest: -3387000.00
CSTE income_statement (quarterly, 2025-06-30) — Minority Interests: 194000.00
CSTE income_statement (quarterly, 2025-06-30) — Net Income: -18554000.00
CSTE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -18554000.00
CSTE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -18748000.00
CSTE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -18554000.00
CSTE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -18554000.00
CSTE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -18748000.00
CSTE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -18748000.00
CSTE income_statement (quarterly, 2025-06-30) — Net Interest Income: -5715000.00
CSTE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -311000.00
CSTE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -5715000.00
CSTE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -124000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Net PPE: 195650000.00
CSTE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3524000.00
CSTE cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: -311000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 252149000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 3099000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2336000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 3099000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2336000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 3620000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 5074000.00
CSTE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -5051000.00
CSTE income_statement (quarterly, 2025-06-30) — Normalized Income: -16967680.00
CSTE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -9879000.00
CSTE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 472000.00
CSTE income_statement (quarterly, 2025-06-30) — Operating Income: -10614000.00
CSTE income_statement (quarterly, 2025-06-30) — Operating Revenue: 101123000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 34549050.00
CSTE balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 35317000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -8746000.00
CSTE income_statement (quarterly, 2025-06-30) — Other Gand A: 9479000.00
CSTE income_statement (quarterly, 2025-06-30) — Other Income Expense: -2008000.00
CSTE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2008000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 9608000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Other Properties: 195650000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 78276000.00
CSTE income_statement (quarterly, 2025-06-30) — Other Special Charges: 1987000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Payables: 53747000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 110320000.00
CSTE cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: 467000.00
CSTE income_statement (quarterly, 2025-06-30) — Pretax Income: -18337000.00
CSTE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3637000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Receivables: 132318000.00
CSTE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 81256000.00
CSTE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 3555000.00
CSTE income_statement (quarterly, 2025-06-30) — Research And Development: 1287000.00
CSTE income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 21000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 132853000.00
CSTE cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 113000.00
CSTE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 19715000.00
CSTE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 29194000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Share Issued: 34549050.00
CSTE income_statement (quarterly, 2025-06-30) — Special Income Charges: -2008000.00
CSTE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 282000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 252236000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 252149000.00
CSTE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -421680.00
CSTE income_statement (quarterly, 2025-06-30) — Tax Provision: 411000.00
CSTE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CSTE balance_sheet (quarterly, 2025-06-30) — Total Assets: 529118000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 252677000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Total Debt: 118215000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 248849000.00
CSTE income_statement (quarterly, 2025-06-30) — Total Expenses: 111737000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 280269000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 205616000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 131401000.00
CSTE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -12622000.00
CSTE income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 5715000.00
CSTE income_statement (quarterly, 2025-06-30) — Total Unusual Items: -2008000.00
CSTE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -2008000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 39430000.00
CSTE balance_sheet (quarterly, 2025-06-30) — Working Capital: 174634000.00
CSTE income_statement (quarterly, 2025-09-30) — +Operating Expense: 29671000.00
CSTE income_statement (quarterly, 2025-09-30) — +Total Revenue: 102112000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 48554000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 54424000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 167459000.00
CSTE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 34564909.00
CSTE income_statement (quarterly, 2025-09-30) — Basic EPS: -0.52
CSTE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 75626000.00
CSTE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -2928000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 110697000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 371000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 69325000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 69325000.00
CSTE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -499000.00
CSTE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2820000.00
CSTE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2886000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -3865000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -445000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Inventory: 10873000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 4222000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -3375000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1365000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Payable: -3865000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -4310000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Receivables: 1770000.00
CSTE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 7815000.00
CSTE cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -545000.00
CSTE cash_flow (quarterly, 2025-09-30) — Changes In Cash: -6205000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Common Stock: 371000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 233328000.00
CSTE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 84477000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 57001000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Current Assets: 301512000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Current Debt: 3054000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3054000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 145540000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 1677000.00
CSTE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 3451000.00
CSTE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 3451000.00
CSTE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 34564909.00
CSTE income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.52
CSTE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -18097000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 241000.00
CSTE income_statement (quarterly, 2025-09-30) — EBIT: -12036000.00
CSTE income_statement (quarterly, 2025-09-30) — EBITDA: -8585000.00
CSTE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -96000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 3259000.00
CSTE cash_flow (quarterly, 2025-09-30) — End Cash Position: 69325000.00
CSTE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -499000.00
CSTE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -5814000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -10041000.00
CSTE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 9266000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 0.00
CSTE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 189399000.00
CSTE income_statement (quarterly, 2025-09-30) — Gross Profit: 17635000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Inventory: 104284000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 236382000.00
CSTE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2820000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 3054000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 110697000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 110697000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 915000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Minority Interest: -3667000.00
CSTE income_statement (quarterly, 2025-09-30) — Minority Interests: -10000.00
CSTE income_statement (quarterly, 2025-09-30) — Net Income: -18097000.00
CSTE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -18097000.00
CSTE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -18087000.00
CSTE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -18097000.00
CSTE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -18097000.00
CSTE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -18087000.00
CSTE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -18087000.00
CSTE income_statement (quarterly, 2025-09-30) — Net Interest Income: -1767000.00
CSTE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -499000.00
CSTE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -1767000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Net PPE: 189399000.00
CSTE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -2887000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 233328000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 4065000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 2211000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 4065000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2211000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 3259000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 5001000.00
CSTE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -4595000.00
CSTE income_statement (quarterly, 2025-09-30) — Normalized Income: -14944900.00
CSTE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2886000.00
CSTE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -326000.00
CSTE income_statement (quarterly, 2025-09-30) — Operating Income: -12036000.00
CSTE income_statement (quarterly, 2025-09-30) — Operating Revenue: 102112000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 34571274.00
CSTE balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 36690000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -10041000.00
CSTE income_statement (quarterly, 2025-09-30) — Other Gand A: 9266000.00
CSTE income_statement (quarterly, 2025-09-30) — Other Income Expense: -3990000.00
CSTE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3990000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 9371000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Other Properties: 189399000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Other Receivables: 73479000.00
CSTE income_statement (quarterly, 2025-09-30) — Other Special Charges: 3976000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Payables: 48795000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 105796000.00
CSTE cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: -329000.00
CSTE income_statement (quarterly, 2025-09-30) — Pretax Income: -17793000.00
CSTE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -2928000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Receivables: 127903000.00
CSTE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 84477000.00
CSTE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 3451000.00
CSTE income_statement (quarterly, 2025-09-30) — Research And Development: 1589000.00
CSTE income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 14000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 114969000.00
CSTE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 41000.00
CSTE income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 18816000.00
CSTE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 28082000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Share Issued: 35674370.00
CSTE income_statement (quarterly, 2025-09-30) — Special Income Charges: -3990000.00
CSTE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 271000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 233328000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 233328000.00
CSTE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -837900.00
CSTE income_statement (quarterly, 2025-09-30) — Tax Provision: 294000.00
CSTE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CSTE balance_sheet (quarterly, 2025-09-30) — Total Assets: 501654000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 233328000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Total Debt: 113751000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 229661000.00
CSTE income_statement (quarterly, 2025-09-30) — Total Expenses: 114148000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 271993000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 200142000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 126453000.00
CSTE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -16026000.00
CSTE income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 1767000.00
CSTE income_statement (quarterly, 2025-09-30) — Total Unusual Items: -3990000.00
CSTE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -3990000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 1103096.00
CSTE balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 39430000.00
CSTE balance_sheet (quarterly, 2025-09-30) — Working Capital: 155972000.00
CSTE income_statement (annual, 2025-12-31) — +Operating Expense: 124681000.00
CSTE income_statement (quarterly, 2025-12-31) — +Operating Expense: 32032000.00
CSTE income_statement (annual, 2025-12-31) — +Total Revenue: 397228000.00
CSTE income_statement (quarterly, 2025-12-31) — +Total Revenue: 94435000.00
CSTE balance_sheet (annual, 2025-12-31) — Accounts Payable: 37779000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 37779000.00
CSTE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 48292000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 48292000.00
CSTE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -56464000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -56464000.00
CSTE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 167700000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 167700000.00
CSTE balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -7327000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -7327000.00
CSTE cash_flow (annual, 2025-12-31) — Amortization Of Securities: 0.00
CSTE cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 48753000.00
CSTE balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 29278000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 29278000.00
CSTE income_statement (annual, 2025-12-31) — Basic Average Shares: 34569215.00
CSTE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 34572774.00
CSTE income_statement (annual, 2025-12-31) — Basic EPS: -3.98
CSTE income_statement (quarterly, 2025-12-31) — Basic EPS: -2.55
CSTE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 57336000.00
CSTE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 69325000.00
CSTE balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 31072000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 31072000.00
CSTE cash_flow (annual, 2025-12-31) — Capital Expenditure: -9036000.00
CSTE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -787000.00
CSTE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 133294000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 133294000.00
CSTE balance_sheet (annual, 2025-12-31) — Capital Stock: 371000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 371000.00
CSTE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 58440000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 58440000.00
CSTE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 59920000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 59920000.00
CSTE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3880000.00
CSTE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2088000.00
CSTE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 41976000.00
CSTE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 50102000.00
CSTE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -38029000.00
CSTE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -10176000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Account Payable: -15342000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -10490000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -18589000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -13623000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Interest Payable: 0.00
CSTE cash_flow (annual, 2025-12-31) — Change In Inventory: 21099000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Inventory: 10221000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 14213000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 13831000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1959000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -5960000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -791000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 177000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Payable: -15342000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Payable: -10490000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -33931000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -24113000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Receivables: 11054000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Receivables: 14502000.00
CSTE cash_flow (annual, 2025-12-31) — Change In Working Capital: 9685000.00
CSTE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 8658000.00
CSTE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 88000.00
CSTE cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 6411000.00
CSTE cash_flow (annual, 2025-12-31) — Changes In Cash: 67000.00
CSTE cash_flow (quarterly, 2025-12-31) — Changes In Cash: 37838000.00
CSTE balance_sheet (annual, 2025-12-31) — Common Stock: 371000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Common Stock: 371000.00
CSTE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 144800000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 144800000.00
CSTE income_statement (annual, 2025-12-31) — Cost Of Revenue: 323948000.00
CSTE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 79827000.00
CSTE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 19625000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 19625000.00
CSTE balance_sheet (annual, 2025-12-31) — Current Assets: 253088000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Current Assets: 253088000.00
CSTE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 26917000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 26917000.00
CSTE balance_sheet (annual, 2025-12-31) — Current Debt: 2853000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Current Debt: 2853000.00
CSTE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 29770000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 29770000.00
CSTE balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 3377000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 3377000.00
CSTE balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3377000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3377000.00
CSTE balance_sheet (annual, 2025-12-31) — Current Liabilities: 138174000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 138174000.00
CSTE balance_sheet (annual, 2025-12-31) — Current Provisions: 1929000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Current Provisions: 1929000.00
CSTE balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 1245000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 1245000.00
CSTE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 14199000.00
CSTE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3769000.00
CSTE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 14199000.00
CSTE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3769000.00
CSTE income_statement (annual, 2025-12-31) — Diluted Average Shares: 34569215.00
CSTE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 34572774.00
CSTE income_statement (annual, 2025-12-31) — Diluted EPS: -3.98
CSTE income_statement (quarterly, 2025-12-31) — Diluted EPS: -2.55
CSTE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -137568000.00
CSTE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -88037000.00
CSTE balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 247000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 247000.00
CSTE income_statement (annual, 2025-12-31) — EBIT: -130832000.00
CSTE income_statement (quarterly, 2025-12-31) — EBIT: -96855000.00
CSTE income_statement (annual, 2025-12-31) — EBITDA: -116633000.00
CSTE income_statement (quarterly, 2025-12-31) — EBITDA: -93086000.00
CSTE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 1037000.00
CSTE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 277000.00
CSTE balance_sheet (annual, 2025-12-31) — Employee Benefits: 2886000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 2886000.00
CSTE cash_flow (annual, 2025-12-31) — End Cash Position: 58440000.00
CSTE cash_flow (quarterly, 2025-12-31) — End Cash Position: 58440000.00
CSTE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -3880000.00
CSTE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -2088000.00
CSTE balance_sheet (annual, 2025-12-31) — Finished Goods: 91558000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Finished Goods: 91558000.00
CSTE cash_flow (annual, 2025-12-31) — Free Cash Flow: -47065000.00
CSTE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -10963000.00
CSTE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 149000.00
CSTE income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -8273000.00
CSTE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -10874000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -10874000.00
CSTE income_statement (annual, 2025-12-31) — General And Administrative Expense: 39486000.00
CSTE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 10381000.00
CSTE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
CSTE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 0.00
CSTE balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 55619000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 55619000.00
CSTE balance_sheet (annual, 2025-12-31) — Gross PPE: 191384000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 191384000.00
CSTE income_statement (annual, 2025-12-31) — Gross Profit: 73280000.00
CSTE income_statement (quarterly, 2025-12-31) — Gross Profit: 14608000.00
CSTE balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 0.00
CSTE balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 0.00
CSTE cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 546000.00
CSTE income_statement (annual, 2025-12-31) — Interest Expense: 2643000.00
CSTE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2643000.00
CSTE income_statement (annual, 2025-12-31) — Interest Income: 3150000.00
CSTE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 3150000.00
CSTE cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 280000.00
CSTE balance_sheet (annual, 2025-12-31) — Inventory: 94275000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Inventory: 94275000.00
CSTE balance_sheet (annual, 2025-12-31) — Invested Capital: 147653000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 147653000.00
CSTE cash_flow (annual, 2025-12-31) — Investing Cash Flow: 41976000.00
CSTE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 50102000.00
CSTE balance_sheet (annual, 2025-12-31) — Line Of Credit: 2431000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 2431000.00
CSTE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 106377000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 106377000.00
CSTE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 106377000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 106377000.00
CSTE balance_sheet (annual, 2025-12-31) — Long Term Provisions: 889000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 889000.00
CSTE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 55538000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 55538000.00
CSTE balance_sheet (annual, 2025-12-31) — Minority Interest: -5587000.00
CSTE balance_sheet (quarterly, 2025-12-31) — Minority Interest: -5587000.00
CSTE income_statement (annual, 2025-12-31) — Minority Interests: 292000.00
CSTE income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
CSTE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
CSTE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CSTE income_statement (annual, 2025-12-31) — Net Income: -137467000.00
CSTE income_statement (quarterly, 2025-12-31) — Net Income: -87936000.00
CSTE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -137568000.00
CSTE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -88037000.00
CSTE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -137759000.00
CSTE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -87936000.00